{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T02:40:56Z","timestamp":1792896056460,"version":"4.5.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":3996,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1016\/j.bbmt.2003.12.305","type":"journal-article","created":{"date-parts":[[2004,4,28]],"date-time":"2004-04-28T08:30:48Z","timestamp":1083141048000},"page":"328-336","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":122,"title":["Sirolimus and tacrolimus without methotrexate as graft-versus-host disease prophylaxis after matched related donor peripheral blood stem cell transplantation"],"prefix":"10.1016","volume":"10","author":[{"given":"Corey","family":"Cutler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haesook T","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ephraim","family":"Hochberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin","family":"Alyea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie J","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Miklos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse","family":"Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Sonis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J","family":"Soiffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph H","family":"Antin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2003.12.305_BIB1","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1182\/blood.V73.6.1729.1729","article-title":"Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia","volume":"73","author":"Storb","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2003.12.305_BIB2","first-page":"3702","article-title":"Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation","volume":"95","author":"Champlin","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2003.12.305_BIB3","doi-asserted-by":"crossref","first-page":"4517","DOI":"10.1182\/blood-2001-11-0062","article-title":"Effect of rapamycin on the cyclosporin A-resistant CD28-mediated costimulatory pathway","volume":"99","author":"Ghosh","year":"2002","journal-title":"Blood"},{"issue":"3 suppl","key":"10.1016\/j.bbmt.2003.12.305_BIB4","doi-asserted-by":"crossref","first-page":"S227","DOI":"10.1016\/S0041-1345(03)00230-6","article-title":"Molecular actions of sirolimus","volume":"35","author":"Kirken","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1016\/j.bbmt.2003.12.305_BIB5","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0009-9120(98)00045-9","article-title":"Rapamune (RAPA, rapamycin, sirolimus)","volume":"31","author":"Sehgal","year":"1998","journal-title":"Clin Biochem"},{"issue":"3 suppl","key":"10.1016\/j.bbmt.2003.12.305_BIB6","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/S0041-1345(03)00211-2","article-title":"Sirolimus","volume":"35","author":"Sehgal","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1016\/j.bbmt.2003.12.305_BIB7","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1182\/blood-2002-11-3370","article-title":"Rapamycin inhibits IL-4-induced dendritic cell maturation in vitro and dendritic cell mobilization and function in vivo","volume":"101","author":"Hackstein","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2003.12.305_BIB8","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1182\/blood.V100.3.1084","article-title":"Rapamycin inhibits macropinocytosis and mannose receptor-mediated endocytosis by bone marrow-derived dendritic cells","volume":"100","author":"Hackstein","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2003.12.305_BIB9","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00007890-200301150-00025","article-title":"Rapamycin impairs antigen uptake of human dendritic cells","volume":"75","author":"Monti","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2003.12.305_BIB10","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1182\/blood.V98.1.174","article-title":"Rapamycin induces apoptosis in monocyte- and CD34-derived dendritic cells but not in monocytes and macrophages","volume":"98","author":"Woltman","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2003.12.305_BIB11","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1182\/blood-2002-06-1688","article-title":"Rapamycin specifically interferes with GM-CSF signaling in human dendritic cells, leading to apoptosis via increased p27KIP1 expression","volume":"101","author":"Woltman","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2003.12.305_BIB12","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/00041552-200211000-00006","article-title":"Sirolimus (Rapamune) in renal transplantation","volume":"11","author":"Johnson","year":"2002","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"3 suppl","key":"10.1016\/j.bbmt.2003.12.305_BIB13","doi-asserted-by":"crossref","first-page":"S193","DOI":"10.1016\/S0041-1345(03)00234-3","article-title":"Sirolimus in liver transplantation","volume":"35","author":"Trotter","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1016\/j.bbmt.2003.12.305_BIB14","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1097\/00007890-200112270-00010","article-title":"Sirolimus (rapamycin) for the treatment of steroid-refractory acute graft-versus-host disease","volume":"72","author":"Benito","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2003.12.305_BIB15","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1083-8791(03)80016-2","article-title":"Sirolimus (rapamycin) for treatment of steroid-refractory chronic graft versus host disease","volume":"9","author":"Couriel","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2003.12.305_BIB16","first-page":"87","article-title":"Rapamycin for treatment of chronic graft versus host disease","volume":"9","author":"Johnston","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2003.12.305_BIB17","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S1083-8791(00)70007-3","article-title":"Equivalence of 2 effective graft-versus-host disease prophylaxis regimens","volume":"6","author":"Chao","year":"2000","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2003.12.305_BIB18","first-page":"85","article-title":"Omission of day +11 methotrexate after matched-related allogeneic peripheral blood stem cell transplantation does not increase the risk of graft-vs.-host disease","volume":"8","author":"Cutler","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2003.12.305_BIB19","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1053\/bbmt.2001.v7.pm11349809","article-title":"Prognostic factors for early severe pulmonary complications after hematopoietic stem cell transplantation","volume":"7","author":"Ho","year":"2001","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2003.12.305_BIB20","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1182\/blood-2003-02-0489","article-title":"Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host disease prophylaxis in mismatched related donor or unrelated donor transplantation","volume":"102","author":"Antin","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2003.12.305_BIB21","first-page":"825","article-title":"1994 Consensus Conference on Acute GVHD Grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2003.12.305_BIB22","article-title":"A site-based scoring system of chemotherapy-induced oral mucositis in bone marrow transplant recipients","author":"Monopoli","year":"1991","journal-title":"Annual meeting of the Society for Oral Oncology"},{"key":"10.1016\/j.bbmt.2003.12.305_BIB23","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/sj.bmt.1701779","article-title":"Rapid quantification of mixed chimerism using multiplex amplification of short tandem repeat markers and fluorescence detection","volume":"23","author":"Thiede","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2003.12.305_BIB24","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.bbmt.2003.12.305_BIB25","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1080\/01621459.1979.10481038","article-title":"Robust locally weighted regression and smoothing scatterplots","volume":"74","author":"Cleveland","year":"1979","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.bbmt.2003.12.305_BIB26","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1182\/blood-2003-01-0255","article-title":"Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantation","volume":"102","author":"Wadleigh","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2003.12.305_BIB27","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1182\/blood-2002-04-1216","article-title":"Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure","volume":"100","author":"Richardson","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2003.12.305_BIB28","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1056\/NEJM200101183440303","article-title":"Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers","volume":"344","author":"Bensinger","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2003.12.305_BIB29","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1182\/blood-2002-01-0048","article-title":"A randomized multicentre comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies","volume":"100","author":"Couban","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2003.12.305_BIB30","first-page":"437","article-title":"Cyclosporine combined with methylprednisolone or methotrexate in prophylaxis of moderate to severe acute graft-versus-host disease","volume":"12","author":"Gondo","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2003.12.305_BIB31","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1182\/blood-2003-05-1597","article-title":"Risks and outcomes of idiopathic pneumonia syndrome after nonmyeloablative compared to conventional conditioning regimens for allogeneic hematopoietic stem cell transplantation","volume":"102","author":"Fukuda","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2003.12.305_BIB32","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000046590","article-title":"Hepatic veno-occlusive disease following hematopoietic stem cell transplantation","volume":"106","author":"Richardson","year":"2001","journal-title":"Acta Haematol"},{"key":"10.1016\/j.bbmt.2003.12.305_BIB33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.bmt.1703776","article-title":"Mucosal injury in patients undergoing hematopoietic progenitor cell transplantation","volume":"31","author":"Filicko","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2003.12.305_BIB34","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/sj.bmt.1703716","article-title":"Quality of life, taste, olfactory and oral function following high-dose chemotherapy and allogeneic hematopoietic cell transplantation","volume":"30","author":"Epstein","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2003.12.305_BIB35","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/sj.bmt.1703870","article-title":"A prospective, randomized trial for the prevention of mucositis in patients undergoing hematopoietic stem cell transplantation","volume":"31","author":"Papas","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2003.12.305_BIB36","first-page":"137","article-title":"Combination of cyclosporin and methotrexate for prophylaxis of acute graft-versus-host disease after allogeneic bone marrow transplantation for leukemia","volume":"6","author":"Mrsic","year":"1990","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2003.12.305_BIB37","first-page":"113","article-title":"Methotrexate combined with cyclosporin A decreases graft-versus-host disease, but increases leukemic relapse compared to monotherapy","volume":"7","author":"Aschan","year":"1991","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2003.12.305_BIB38","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/sj.bmt.1703053","article-title":"Prophylaxis of graft-versus-host disease with cyclosporine-prednisone is associated with increased risk of chronic graft-versus-host disease","volume":"27","author":"Kumar","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2003.12.305_BIB39","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1182\/blood.V98.6.1695","article-title":"Chronic graft-versus-host disease after allogeneic blood stem cell transplantation","volume":"98","author":"Przepiorka","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2003.12.305_BIB40","first-page":"25","article-title":"The outcome of unrelated donor bone marrow transplantation in patients with hematologic malignancies using tacrolimus (FK506) and low dose methotrexate for graft-versus-host disease prophylaxis","volume":"3","author":"Devine","year":"1997","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2003.12.305_BIB41","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/sj.bmt.1701983","article-title":"Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after HLA-mismatched marrow or blood stem cell transplantation","volume":"24","author":"Przepiorka","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2003.12.305_BIB42","first-page":"409","article-title":"Allogeneic bone marrow or peripheral blood cell transplants in adults with hematologic malignancies","volume":"26","author":"Bacigalupo","year":"1998","journal-title":"Exp Hematol"},{"key":"10.1016\/j.bbmt.2003.12.305_BIB43","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1200\/JCO.2000.18.3.537","article-title":"Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia","volume":"18","author":"Blaise","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2003.12.305_BIB44","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1200\/JCO.1997.15.4.1608","article-title":"Hematopoietic recovery after allogeneic blood stem-cell transplantation compared with bone marrow transplantation in patients with hematologic malignancies","volume":"15","author":"Pavletic","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2003.12.305_BIB45","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1182\/blood-2001-12-0304","article-title":"Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia","volume":"100","author":"Schmitz","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2003.12.305_BIB46","first-page":"755","article-title":"Omission of day 11 methotrexate does not appear to influence the incidence of moderate to severe acute graft-versus-host disease, chronic graft-versus-host disease, relapse rate or survival after HLA-identical sibling bone marrow transplantation","volume":"16","author":"Atkinson","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2003.12.305_BIB47","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/sj.bmt.1703616","article-title":"Omission of day +11 methotrexate after allogeneic bone marrow transplantation is associated with increased risk of severe acute graft-versus-host disease","volume":"30","author":"Kumar","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2003.12.305_BIB48","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1182\/blood.V87.8.3514.bloodjournal8783514","article-title":"FK506 (Tacrolimus) monotherapy for prevention of graft-versus-host disease after histocompatible sibling allogeneic bone marrow transplantation","volume":"87","author":"Fay","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2003.12.305_BIB49","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1083-8791(03)80110-6","article-title":"Single-agent tacrolimus for prophylaxis of acute graft-versus-host disease after related allogeneic peripheral blood stem cell transplantation","volume":"9","author":"Schwartz","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2003.12.305_BIB50","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1200\/JCO.2001.19.16.3685","article-title":"Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation","volume":"19","author":"Cutler","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2003.12.305_BIB51","series-title":"Hematopoietic Cell Transplantation","first-page":"305","article-title":"The pathophysiology of graft-vs.-host disease","author":"Ferrara","year":"1999"},{"key":"10.1016\/j.bbmt.2003.12.305_BIB52","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1182\/blood.V95.9.2754.009k25_2754_2759","article-title":"The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease","volume":"95","author":"Hill","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2003.12.305_BIB53","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.4049\/jimmunol.166.5.3201","article-title":"Uncoupling p70(s6) kinase activation and proliferation","volume":"166","author":"Slavik","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.bbmt.2003.12.305_BIB54","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1182\/blood.V82.7.2216.2216","article-title":"Prediction of graft-versus-host disease by phenotypic analysis of early immune reconstitution after CD6-depleted allogeneic bone marrow transplantation","volume":"82","author":"Soiffer","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2003.12.305_BIB55","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1097\/01.TP.0000053752.87383.67","article-title":"Superior T-cell suppression by rapamycin and FK506 over rapamycin and cyclosporine A because of abrogated cytotoxic T-lymphocyte induction, impaired memory responses, and persistent apoptosis","volume":"75","author":"Koenen","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2003.12.305_BIB56","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/jca.10030","article-title":"Thrombotic microangiopathies in bone marrow and organ transplant patients","volume":"17","author":"McLeod","year":"2002","journal-title":"J Clin Apheresis"},{"key":"10.1016\/j.bbmt.2003.12.305_BIB57","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/00007890-200203150-00017","article-title":"De novo hemolytic uremic syndrome after kidney transplantation in patients treated with cyclosporine-sirolimus combination","volume":"73","author":"Langer","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2003.12.305_BIB58","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1034\/j.1600-6143.2003.00051.x","article-title":"Thrombotic micro-angiopathy with sirolimus-based immunosuppression","volume":"3","author":"Robson","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1016\/j.bbmt.2003.12.305_BIB59","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1034\/j.1600-6143.2003.00018.x","article-title":"Sirolimus may promote thrombotic microangiopathy","volume":"3","author":"Saikali","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1016\/j.bbmt.2003.12.305_BIB60","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0272-6386(03)00424-4","article-title":"Sirolimus-induced thrombotic microangiopathy in a renal transplant recipient","volume":"42","author":"Barone","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.bbmt.2003.12.305_BIB61","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1093\/ndt\/17.8.1524","article-title":"Sirolimus-based immunosuppression for transplant-associated thrombotic microangiopathy","volume":"17","author":"Edwards","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.bbmt.2003.12.305_BIB62","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000057626","article-title":"Hemolytic uremic syndrome after renal transplantation","volume":"91","author":"Heering","year":"2002","journal-title":"Nephron"},{"key":"10.1016\/j.bbmt.2003.12.305_BIB63","doi-asserted-by":"crossref","first-page":"77","DOI":"10.5414\/CNP58077","article-title":"Successful treatment of tacrolimus-associated thrombotic microangiopathy with sirolimus conversion and plasma exchange","volume":"58","author":"Yango","year":"2002","journal-title":"Clin Nephrol"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879104000035?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879104000035?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:20:07Z","timestamp":1761056407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879104000035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":63,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["S1083879104000035"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2003.12.305","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2004,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sirolimus and tacrolimus without methotrexate as graft-versus-host disease prophylaxis after matched related donor peripheral blood stem cell transplantation","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2003.12.305","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}